Bond Screener
Novartis AG
LEI 5493007HIVTX6SY6XD66, SWIFT NOVRCHBSXXX
Organization name
Novartis AG
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
38,011 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Novartis manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases, oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, arthritis, vaccines and diagnostics, vision, and animal health products.
|
General information
-
Organization nameNovartis AG
-
Organization statusOperating organization
-
AddressLichtstrasse 35 Basel, Switzerland, 4056
-
Site
-
IR Site
News
-
Novartis Halts Development Of VHB937 After ASTRALS Phase 2 Trial Fails To Meet Endpoint17/09/2026
-
Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.14/09/2026
-
Breakingviews - COMMENTARY: For Novartis, M&A is both a disease and cure11/09/2026
-
Novartis (NYSE: NVS) Navigates Clinical Setbacks and Stock Rating Adjustment10/09/2026
-
Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall09/09/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameNovartis AG
-
Organization statusOperating organization
-
AddressLichtstrasse 35 Basel, Switzerland, 4056
-
Site
-
IR Site
Codes
-
LEI5493007HIVTX6SY6XD66
-
SWIFTNOVRCHBSXXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0001114448
-
UIDCHE103867266
